How a drug company courts news coverage to create demand for a new drug

| No Comments | No TrackBacks

The Wall Street Journal Health Blog published an interesting inside look of - as they put it - "how drug makers can try to lay the groundwork for sales well before a new therapy hits the market."

The topic is premature ejaculation.

Some might call the methods "disease-mongering."

No TrackBacks

TrackBack URL: http://www.healthnewsreview.org/blog/mt-tb.cgi/7144

Leave a comment.

Enter Comments, but.... I welcome comments but will delete those with product pitches, profanity, personal attacks or those from anyone who doesn't list what appears to be an actual e-mail address. We also don' t give medical advice and won't respond to any questions asking for it.

About this Entry

This page contains a single entry by Gary Schwitzer published on December 9, 2009 8:04 AM.

Star Tribune gives one-sided view of FDA medical device approval process was the previous entry in this blog.

CNN fear-mongering, screening advocacy on kids' hearts tests is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.